An Evaluation of Two Dose Routes of HDV [hepatocyte delivery vehicle] -Interferon [interferons] Administered With Ribavarin [ribavirin] in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Trial Profile

An Evaluation of Two Dose Routes of HDV [hepatocyte delivery vehicle] -Interferon [interferons] Administered With Ribavarin [ribavirin] in the Treatment of Chronic Hepatitis C Nonresponders and Naive Hepatitis C Patients

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jan 2009

At a glance

  • Drugs Interferons; Interferons; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 21 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top